Spyre Therapeutics stock hits 52-week high at 108.16 USD
First publishedAug 18, 15:34 UTC
Last updatedAug 19, 17:13 UTC · 11m ago
1 outlet
Investing.com · Company News1 outletInvesting.com · Company News1 outletInvesting.com · Company News3 outletsInvesting.com · Company News3 outletsInvesting.com · Company News
9 outlets over time — hover a bar for its window & outletslast updated
Answer
Spyre Therapeutics stock hits 52-week high at 108.16 USD.
Reported by 9 outlets — Investing.com · Company News. See all sources ↓
Why it matters
9 outlets are covering this world story — one to watch as reporting develops.
In brief
- What's the story?
- Spyre Therapeutics stock hits 52-week high at 108.16 USD.
- How widely is it covered?
- 9 outlets, average source rating 5.0/10.
- When was it last updated?
- 11m ago.
Different angles across outlets
Coverage map
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Vertex Pharmaceuticals stock hits all-time high at 546.17 USD
Sources1TypeCoverage
Related in the knowledge graph
Sources (9)
Avg source rating 5.0/10
Processing cluster
A1A2A3B1B2B3